Eyenovia Inc (EYEN) Stock Price, Quote & News

Company Profile

Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and...

Industry: Biotechnology

Sector: Healthcare

Phone: 917 289 1117

Website: www.eyenovia.com

Address:

295 Madison Avenue, Suite 2400, New York, United States

cheating_stock_investor Jun. 27 at 10:58 PM

$EYEN new filings this afternoon with updated prospectus and clarification on the upcoming restructuring. I would suggest if you have shares in this to hang on for more good things. All the other companies trying to get attention for crypto treasury reserves this blows them out of the water because we will be with the most up and coming $HYPE.x tokens. If management is listening i suggest they spin off optejet with the merger of betaliq as a new company with $HYPD as a part shareholder. Per the registrations Michael Rowe is eligible to retire nov 5 2025 so i assume thats the time frame the ceo of Betaliq can run both under one umbrella. Newly appointed cio can handle hype treasury. Win win for all shareholders as Mike Rowe has promised!

0 · Reply

Avocado_smash Jun. 27 at 9:59 PM

$EYEN what wii be the range for Monday?

1 · Reply

IntraTrades Jun. 27 at 9:36 PM

$RCT 101.24% $SERA 95.69% $AMIX 46.72% $SVRE 32.92% $EYEN 29.83%

0 · Reply

cheating_stock_investor Jun. 27 at 9:28 PM

$EYEN https://www.hypecapital.co/

0 · Reply

topstockalerts Jun. 27 at 9:14 PM

Todays Top Gainers PT2 $SOND $ODYS $SVRE $EYEN $AUUD

0 · Reply

cheating_stock_investor Jun. 27 at 9:06 PM

$EYEN "The steps we are taking are intended to provide the best vehicle for retail and institutional investors to access HYPE and its native yield in a secure, custodied environment,” said Hyunsu Jung, Chief Investment Officer of Eyenovia. “The Company’s successful purchase of our initial HYPE position paves the way for deeper engagement in the Hyperliquid ecosystem.” I expect after the ticker you will see more institutional funds that are familiar with the crypto ecosystem to invest in this company. For those who aren't aware, $BNB.X is a $90B mc coin. Binance handles 14billion in daily transactions. Hyperliquid is rapidly catching up with 6 billion daily.

0 · Reply

cheating_stock_investor Jun. 27 at 8:57 PM

$EYEN so my finding reveal after the ticker name change the company will focus on being the corporate partner publicly listed for the hyperion exchange https://www.prnewswire.com/news-releases/hyperion-closes-strategic-funding-round-led-by-okx-ventures-to-accelerate-unified-liquidity-and-trading-layer-on-aptos-302478936.html

0 · Reply

Ntb24 Jun. 27 at 8:49 PM

$EYEN wow I do regret selling at $3 and $5 ranges, does anything think it will trend higher after the ticker change, I think it could trend in 15 plus possibly 20, does anyone know what happened with betaliq merger seems no news, I will probably get back in sometime next week accordingly.

0 · Reply

Pumpb0t Jun. 27 at 8:28 PM

$CRML $EYEN $WAI $CTNM $BANL

0 · Reply

dbr_island Jun. 27 at 8:03 PM

🚨🚨🚨 $AMIX all eyes will be on this ticker And also $LFWD 👈 After the nice run on $AUUD $CTOR $EYEN

0 · Reply

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL VVPR

Jun 18, 2025, 8:32 AM EDT - 9 days ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 17, 2025, 3:54 PM EDT - 10 days ago

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 2:55 PM EDT - 10 days ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

May 19, 2025, 5:30 PM EDT - 5 weeks ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Apr 10, 2025, 7:00 AM EDT - 2 months ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Mar 20, 2025, 7:00 AM EDT - 3 months ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Feb 26, 2025, 7:00 AM EST - 4 months ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 24, 2025, 7:00 AM EST - 4 months ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 5, 2025, 7:00 AM EST - 5 months ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Jan 28, 2025, 4:05 PM EST - 5 months ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 15, 2025, 7:00 AM EST - 5 months ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 6, 2025, 7:00 AM EST - 6 months ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Dec 6, 2024, 8:00 AM EST - 7 months ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Nov 22, 2024, 7:00 AM EST - 7 months ago

Eyenovia Provides Update on Restructuring Efforts

Nov 15, 2024, 1:15 PM EST - 8 months ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 7:07 AM EST - 8 months ago

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:00 AM EST - 8 months ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 12, 2024, 10:42 PM EST - 8 months ago

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 8 months ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Oct 16, 2024, 7:00 AM EDT - 9 months ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 1, 2024, 7:00 AM EDT - 9 months ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Sep 27, 2024, 8:30 AM EDT - 9 months ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 26, 2024, 7:00 AM EDT - 9 months ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 9, 2024, 3:00 AM EDT - 10 months ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 5, 2024, 7:00 AM EDT - 10 months ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 3, 2024, 7:00 AM EDT - 10 months ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Aug 23, 2024, 11:42 AM EDT - 11 months ago

Eyenovia Announces Closing of Public Offering

Aug 22, 2024, 2:20 PM EDT - 11 months ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 21, 2024, 9:29 AM EDT - 11 months ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 20, 2024, 5:09 PM EDT - 11 months ago

Eyenovia, Inc. Announces Proposed Public Offering

Aug 12, 2024, 11:07 PM EDT - 11 months ago

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 11 months ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024, 7:00 AM EDT - 11 months ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 7, 2024, 5:11 PM EDT - 11 months ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 8:00 AM EDT - 11 months ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Jul 30, 2024, 8:00 AM EDT - 11 months ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

NBY

Jun 28, 2024, 8:00 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5M Registered Direct Offering

May 17, 2024, 9:12 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:01 PM EDT - 1 year ago

Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol

May 14, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th

Apr 25, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension

Apr 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities

Apr 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings

Mar 18, 2024, 8:52 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q4 2023 Earnings Call Transcript

Mar 18, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Mar 13, 2024, 7:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals

Mar 11, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th

cheating_stock_investor Jun. 27 at 10:58 PM

0 · Reply

Avocado_smash Jun. 27 at 9:59 PM

$EYEN what wii be the range for Monday?

1 · Reply

IntraTrades Jun. 27 at 9:36 PM

$RCT 101.24% $SERA 95.69% $AMIX 46.72% $SVRE 32.92% $EYEN 29.83%

0 · Reply

cheating_stock_investor Jun. 27 at 9:28 PM

$EYEN https://www.hypecapital.co/

0 · Reply

topstockalerts Jun. 27 at 9:14 PM

Todays Top Gainers PT2 $SOND $ODYS $SVRE $EYEN $AUUD

0 · Reply

cheating_stock_investor Jun. 27 at 9:06 PM

0 · Reply

cheating_stock_investor Jun. 27 at 8:57 PM

0 · Reply

Ntb24 Jun. 27 at 8:49 PM

0 · Reply

Pumpb0t Jun. 27 at 8:28 PM

$CRML $EYEN $WAI $CTNM $BANL

0 · Reply

dbr_island Jun. 27 at 8:03 PM

🚨🚨🚨 $AMIX all eyes will be on this ticker And also $LFWD 👈 After the nice run on $AUUD $CTOR $EYEN

0 · Reply

_www_larval_com_ Jun. 27 at 7:57 PM

$AUUD -9%[37%] $LIVE -7%[10%] $GALT -6%[7%] $EYEN -6%[34%] $BDMD -5%[-12%] most notable movement into the final minutes of trading.

0 · Reply

jchords Jun. 27 at 7:54 PM

$EYEN good day here today

0 · Reply

Zaksab Jun. 27 at 7:42 PM

$EYEN some seriously illegal shit going on here

3 · Reply

dbr_island Jun. 27 at 7:37 PM

$AMIX everything that’s happening now I predicted it was going to happen LFWD it’s your turn soon 👈 🚨🚨🚨 $CTOR $EYEN $LCFY $VOR let’s all make big money

0 · Reply

dbr_island Jun. 27 at 7:34 PM

$AMIX is paying HUGE 💰💰💰💰 $LFWD Medicare run coming 5 steps ahead of the market $EYEN $LCFY $RCT let’s get it

0 · Reply

JasCob29 Jun. 27 at 7:32 PM

$ASTI wack in the big buys for the big returns $EYEN

0 · Reply

Pumpb0t Jun. 27 at 7:31 PM

$CRML has the $EYEN vibe... could get one more day of pullback... the hardest thing to predict is which one shorty's gonna attack next

0 · Reply

Pumpb0t Jun. 27 at 7:10 PM

$EYEN

0 · Reply

IMANEEDSMONEY Jun. 27 at 6:58 PM

$EYEN @ Work can't enjoy watching the stock today. I'm still hold not selling yet, but

0 · Reply

dbr_island Jun. 27 at 6:57 PM

$LFWD Medicare run folks 🚢📦📦📦📦📦📦 $AMIX $CTOR $EYEN $VOR what a day 💰💰💰

0 · Reply

JasCob29 Jun. 27 at 6:57 PM

$ASTI lwts gooooo!!! $RTC $EYEN $RCT $LCFY

0 · Reply

Sarahsanjose2 Jun. 27 at 6:56 PM

$AMIX $EYEN $RCT I may see more legs, 15$ ?

0 · Reply

Market Cap	27.53M
Revenue (ttm)	60,000.00
Net Income (ttm)	-49.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-83,033.33%
Debt to Equity Ratio	-0.96

Volume	6,024,800
Avg Vol	5,182,960
Day's Range	N/A - N/A
Shares Out	2.88M
Stochastic %K	62%
Beta	1.00
Analysts	Hold
Price Target	$2.00